HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Pathogenesis of autoantibodies in demyelinating disorders of the central nervous system].

Abstract
Several autoantibodies in relation to central nervous system demyelinating diseases (CDD) have been reported. Among them, anti-aquaporin 4(AQP4) antibody in neuromyelitis optica (NMO) is a reliable marker for the diagnosis of NMO and the antibody is thought to be closely related to its pathogenesis. Another antibody, anti-myelin oligodendrocyte glycoprotein (MOG) antibody is recently recognized in relevance to CDD, especially in seronegative NMO. Anti-MOG antibodies are also paid attention in pediatric acute disseminated encephalomyelitis (ADEM) and optic neuritis, however the roles for the pathogenesis in these disorders are still not clear. Generally, B cells and autoantibodies are thought to have certain roles in CDD.
AuthorsKeiko Tanaka, Masami Tanaka
JournalNihon rinsho. Japanese journal of clinical medicine (Nihon Rinsho) Vol. 72 Issue 11 Pg. 2067-72 (Nov 2014) ISSN: 0047-1852 [Print] Japan
PMID25518394 (Publication Type: English Abstract, Journal Article)
Chemical References
  • Aquaporin 4
  • Autoantibodies
Topics
  • Aquaporin 4 (immunology)
  • Autoantibodies (immunology)
  • B-Lymphocytes (immunology)
  • Central Nervous System (immunology)
  • Humans
  • Neuromyelitis Optica (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: